Nicole M. Lykens, PhD - Publications

Affiliations: 
Drug Development LifeSplice Pharma 
Area:
Neurological disorders

0/2 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
Low-probability matches (unlikely to be authored by this person)
2008 Sirsi SR, Schray RC, Guan X, Lykens NM, Williams JH, Erney ML, Lutz GJ. Functionalized PEG-PEI copolymers complexed to exon-skipping oligonucleotides improve dystrophin expression in mdx mice. Human Gene Therapy. 19: 795-806. PMID 18647087 DOI: 10.1089/Hum.2007.129  0.272
2017 Lykens NM, Coughlin DJ, Reddi JM, Lutz GJ, Tallent MK. AMPA GluA1-flip targeted oligonucleotide therapy reduces neonatal seizures and hyperexcitability. Plos One. 12: e0171538. PMID 28178321 DOI: 10.1371/Journal.Pone.0171538  0.084
Hide low-probability matches.